SITRYX THERAPEUTICS LIMITED
Company number 10366466 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2016-09-08
- Registered office
- 101 Bellhouse Building Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA
- Postcode
- OX4 4GA
- Capital
- 4 GBP
- Accounts category
- Group
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-09-07
- Next due by
- 2026-09-21
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 12 current · 8 resigned
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Data protection registration
Registered with the ICO as a data protection fee payer — ZA393114 (Tier 2), registered since 2018.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- sitryx.com
- Phone
- 03031231113
Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation.
Previous registered addresses 1
| Address | Changed on |
|---|---|
| 71 KINGSWAY, LONDON, WC2B 6ST, UNITED KINGDOM | 2019-02-20 |
The class of 2016
36%
of the 402 companies in this sector incorporated in 2016 are still active today; 59% have since been dissolved.
A fact about the year, not a forecast for this company.